Skip to main content
Clinical Trials/NCT05236088
NCT05236088
Unknown
Not Applicable

The Effects of Neuromuscular Electrical Stimulation in Individuals With Urinary Incontinence After Prostatectomy

Ankara Yildirim Beyazıt University0 sites50 target enrollmentMarch 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Urinary Incontinence
Sponsor
Ankara Yildirim Beyazıt University
Enrollment
50
Primary Endpoint
Urinary incontinence severity
Last Updated
4 years ago

Overview

Brief Summary

The aim of this study is to investigate the effects of neuromuscular electric stimulation on urinary symptoms, quality of life, sexual function, perception of improvement and patient satisfaction in individuals with post-prostatectomy urinary incontinence

Detailed Description

One of the two most common complications after prostatectomy surgeries is urinary incontinence (UI) and the other is erectile dysfunction. There are conservative and surgical treatment options in post-prostatectomy urinary incontinence. One of the conservative treatment options is neuromuscular electrical stimulation application. Since electrical stimulation applications, used in the treatment of post-prostatectomy urinary incontinence, are usually given together with other treatment protocols, there are limitations in clearly demonstrating the effects of neuromuscular electrical stimulation on post-prostatectomy urinary incontinence.

Registry
clinicaltrials.gov
Start Date
March 2022
End Date
March 2023
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Sponsor
Ankara Yildirim Beyazıt University
Responsible Party
Principal Investigator
Principal Investigator

seyda toprak celenay

associate professor

Ankara Yildirim Beyazıt University

Eligibility Criteria

Inclusion Criteria

  • Being a male individual with stress or stress-dominant mixed urinary incontinence symptoms after undergoing prostatectomy surgery in the urology clinic
  • Being over 40 years old
  • Volunteering to participate in the study

Exclusion Criteria

  • Severe cardiovascular disease (unstable angina and arrhythmia patients, heart failure patients ect.)
  • Those with sensory loss
  • Presence of ongoing urinary infection
  • Only urgency urinary incontinence
  • Having a pacemaker
  • Active cancer treatment (radiotherapy, chemotherapy),
  • Those who have undergone Transurethral Prostatectomy (TUR-P) surgery
  • Those who have a problem that interferes with cooperation and understanding

Outcomes

Primary Outcomes

Urinary incontinence severity

Time Frame: change from baseline at 4 weeks

Urinary incontinence severity will be assess with a 1-hour pad test. This amount; less than 2 grams is considered normal, 2-10 grams is mild, 10-50 grams is moderate, and 50 grams is severe stress urinary incontinence.

Secondary Outcomes

  • Sexual function(change from baseline at 4 weeks)
  • Patient satisfaction(after treatment (4th week))
  • Presence of urinary incontinence symptoms(change from baseline at 4 weeks)
  • Life quality(change from baseline at 4 weeks)
  • Patients' subjective perception of improvement(after treatment (4th week))

Similar Trials